Aptamer Group plc, the leading developer of next-generation synthetic binders delivering innovation to the life science ...

AstraZeneca and British American Tobacco today provided fresh support for the FTSE 100 index at the end of a positive week ...

The Chicago-based Tempus spinout called the financing round a major milestone as it expands its AI-enabled platform.

Tezepelumab demonstrated rapid and sustained clinical improvements in nasal polyp burden and symptom control, with effects ...

Ironwood Pharmaceuticals, Inc.’s IRWD share price has dipped by 5.28%, which has investors questioning if this is right time to buy.

The treatment, branded as Emrelis, belongs to a class of drugs known as antibody-drug conjugates, which act as ...

Controlling the entire cell therapy production process—from material receipt to product release—is “essential,” according to AstraZeneca, which says its new $300 million manufacturing facility will be ...

A consultancy’s new ranking of drug company R&D shows Eli Lilly has risen to the top of the drug development heap, while ...

Scientists at EPFL and AstraZeneca have developed a method to map the atomic-level structure of amorphous drugs, demonstrated ...

Food allergy in children with atopic dermatitis is associated with an increased risk for asthma, allergic rhinitis, and ...

In 2024 alone, Singapore secured S$13.5 billion in fixed asset investment commitments, with the biomedical sector ...